Henrik Stenqvist
Finanzdirektor/CFO bei SWEDISH ORPHAN BIOVITRUM AB
Vermögen: 2 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Henrik Stenqvist
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 39 | |
25
| Public Company | Pharmaceuticals: Major | 25 |
| Public Company | Pharmaceuticals: Major | 23 | |
| Subsidiary | Pharmaceuticals: Major | 18 | |
12
| Public Company | Pharmaceuticals: Other | 12 |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Swedish Orphan Biovitrum Ltd.
 Swedish Orphan Biovitrum Ltd. Pharmaceuticals: MajorHealth Technology Part of Swedish Orphan Biovitrum AB, Swedish Orphan Biovitrum Ltd. manufactures and sells drugs for rare diseases. The company is based in Cambridge, UK and was founded in 2002.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Henrik Stenqvist
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Lund | College/University | Masters Business Admin Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin Director/Board Member Graduate Degree Graduate Degree | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Public Communications Contact Chief Executive Officer Director/Board Member | |
| University of Helsinki | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Stockholm | College/University | Doctorate Degree Undergraduate Degree Masters Business Admin | |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal General Counsel | |
| LIQUIDIA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member General Counsel | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact Corporate Officer/Principal | |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Chief Executive Officer Chief Executive Officer General Counsel | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Operating Officer | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President Corporate Officer/Principal | |
| VERONA PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer General Counsel | |
| MEDA AB | Pharmaceuticals: Major | Investor Relations Contact Director/Board Member Director/Board Member | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Biotechnology | Chairman Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
| University of Uppsala | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| NOKIA OYJ | Telecommunications Equipment | Human Resources Officer Corporate Officer/Principal | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Orion Pharma (UK) Ltd.
 Orion Pharma (UK) Ltd. Medical DistributorsDistribution Services Part of Orion Oyj, Orion Pharma (UK) Ltd. is a British company that wholesales and distributes pharmaceutical products. The company is based in Newbury, UK. Orion Pharma (UK was founded in 1996. | Medical Distributors | Director/Board Member Director/Board Member | |
ORION Pharma GmbH
 ORION Pharma GmbH Pharmaceuticals: MajorHealth Technology Part of Orion Oyj, ORION Pharma GmbH is a German company that develops, manufactures, and markets human and veterinary medicines. The company is based in Hamburg, Germany. The CEOs are Robert Borgdorf, Satu Maarit Ahomäki, Jari Ilmari Karlson. The company was founded in 1991. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Operating Officer Sales & Marketing | |
| ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Chairman Director/Board Member | |
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Evecxia, Inc.
 Evecxia, Inc. Miscellaneous Commercial ServicesCommercial Services Evecxia, Inc. is engaged in biotechnology services. The company was founded by Jacob Jacobsen and Marc Caron and is headquartered in Research Triangle Park, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| HKSCAN OYJ | Food: Specialty/Candy | Chief Executive Officer Corporate Officer/Principal | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Georgia State University | College/University | Graduate Degree Masters Business Admin | |
| University of South Carolina | College/University | Graduate Degree Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| University of Gothenburg | College/University | Doctorate Degree Graduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| ELISA OYJ | Wireless Telecommunications | Chief Executive Officer Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
Elinkeinoelämän Keskusliitto ry
 Elinkeinoelämän Keskusliitto ry Miscellaneous Commercial ServicesCommercial Services Elinkeinoelämän Keskusliitto ry is a business organization based in Helsinki, Finland. and has subsidiaries in Finland. The Finnish company operates as a business organization. The CEO of the private company is Jyri Jukka Häkämies. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Aalto University School of Science & Technology | College/University | Graduate Degree Graduate Degree |
Statistik
International
| Schweden | 15 |
| Vereinigte Staaten | 15 |
| Finnland | 7 |
| Vereinigtes Königreich | 5 |
| Dänemark | 5 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 15 |
| Commercial Services | 6 |
| Finance | 4 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 371 |
| Corporate Officer/Principal | 161 |
| Independent Dir/Board Member | 112 |
| Chairman | 109 |
| Chief Executive Officer | 72 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Sven Håkan Björklund | 46 |
| Bo Jesper Hansen | 34 |
| Elmar Schnee | 31 |
| Sean Stalfort | 28 |
| Renée Aguiar-Lucander | 26 |
| Paul Manning | 26 |
| Ari Tapio Lehtoranta | 23 |
| Veli-Matti Johannes Mattila | 22 |
| Johannes G. C. P. Schikan | 22 |
| Ola Harald Erici | 22 |
| Hilde Furberg | 21 |
| Fred Driscoll | 21 |
| Nancy Wysenski | 20 |
| Alfred Novak | 19 |
| Anders Egon Svensson | 19 |
- Börse
- Insiders
- Henrik Stenqvist
- Unternehmensverbindungen
